News
IRADIMED CORPORATION Revises Financial Guidance for the Third Quarter and Full Year 2016
Schedules conference call for 8:30 AM Eastern Time on Tuesday, October 4, 2016 WINTER SPRINGS, Fla., Oct. 04, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD), today revised its third quarter and full year 2016 financial guidance. The Company now expects revenue for the...
IRADIMED CORPORATION Announces Second Quarter 2016 Financial Results
Revenue grows 29.7% compared to the same quarter last yearReports second quarter 2016 GAAP diluted EPS of $0.19 and non-GAAP diluted EPS of $0.24Increases full year 2016 non-GAAP earnings guidanceSubmits patient vital signs monitor 510(k) application to FDA for review...
IRADIMED CORPORATION to Hold 2016 Second Quarter Financial Results Conference Call on July 29th
WINTER SPRINGS, Fla., July 15, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2016 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same day...
IRADIMED CORPORATION Announces Appointment of Jonathan Kennedy to its Board of Directors
WINTER SPRINGS, Fla., June 28, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Jonathan Kennedy has been appointed to the Company's Board of Directors. Mr. Kennedy, 45, currently serves as Senior Vice President and Chief Financial Officer of Natus...
IRADIMED CORPORATION Announces Election of Roger Susi as Chairman of the Board
WINTER SPRINGS, Fla., June 14, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that its Board of Directors voted unanimously to appoint current President and Chief Executive Officer, Roger Susi, as Chairman of the Board. The appointment was effective as of...
IRADIMED CORPORATION Provides Regulatory Update
Provides regulatory update on the status of its MRI compatible IV infusion pump WINTER SPRINGS, Fla., June 09, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD) CURRENT NEWSIRADIMED CORPORATION has received the FDA's written response to our appeal of their determination that...
IRADIMED CORPORATION Announces First Quarter 2016 Financial Results
Revenue grows 28.2% compared to the same quarter last yearReports first quarter 2016 non-GAAP diluted EPS of $0.21Increases full year 2016 non-GAAP earnings guidanceAnnounces second quarter financial guidance WINTER SPRINGS, Fla., April 29, 2016 -- IRADIMED...